Company performance
Add to research
Current Price
as of Feb 07, 2025$19.93
P/E Ratio
N/A
Market Cap
$50.56M
Description
Add to research
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerOMIC
- Price$19.93+0.15%
Trading Information
- Market cap$50.56M
- Float60.60%
- Average Daily Volume (1m)6,821
- Average Daily Volume (3m)14,024
- EPS-$34.92
Company
- Revenue$2.67M
- Rev growth (1yr)-12.12%
- Net income-$16.79M
- Gross margin-490.64%
- EBITDA margin-4,034.48%
- EBITDA-$16.38M
- EV-$18.98M
- EV/Revenue-7.12
- P/EN/A
- P/S18.70
- P/B0.41
- Debt/Equity45.16
Documents
Add to research
SEC Filings
Earnings Calls